These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33964903)

  • 1. A five metastasis-related long noncoding RNA risk signature for osteosarcoma survival prediction.
    Yu S; Shao F; Liu H; Liu Q
    BMC Med Genomics; 2021 May; 14(1):124. PubMed ID: 33964903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A four-lncRNA risk signature for prognostic prediction of osteosarcoma.
    Liu H; Chen C; Liu L; Wang Z
    Front Genet; 2022; 13():1081478. PubMed ID: 36685868
    [No Abstract]   [Full Text] [Related]  

  • 3. The lncRNAs RP1-261G23.7, RP11-69E11.4 and SATB2-AS1 are a novel clinical signature for predicting recurrent osteosarcoma.
    Ying T; Dong JL; Yuan C; Li P; Guo Q
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of long noncoding RNA AC083900.1 and RP11-283C24.1 for prediction of progression of osteosarcoma.
    Huang L; Jin W; Bao Y; Zeng X; Zhang Y; Zhou J; Peng H
    Mutat Res; 2023; 827():111828. PubMed ID: 37437507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q; Liu B
    Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic five long-noncoding RNA signature for patients with rectal cancer.
    Zhao K; Wang M; Kang H; Wu A
    J Cell Biochem; 2020 Aug; 121(8-9):3854-3860. PubMed ID: 31709598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A four-methylated LncRNA signature predicts survival of osteosarcoma patients based on machine learning.
    Deng Y; Yuan W; Ren E; Wu Z; Zhang G; Xie Q
    Genomics; 2021 Jan; 113(1 Pt 2):785-794. PubMed ID: 33069828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis.
    Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y
    Front Genet; 2022; 13():760514. PubMed ID: 35273635
    [No Abstract]   [Full Text] [Related]  

  • 13. Circadian rhythm-associated lncRNA RP11-414H17.5 as a key therapeutic target in osteosarcoma affects the tumor immune microenvironment and enhances malignancy.
    Huang L; Liang W; Cai W; Peng H
    J Orthop Surg Res; 2023 Dec; 18(1):947. PubMed ID: 38071320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma.
    Cai L; Lv J; Zhang Y; Li J; Wang Y; Yang H
    J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
    Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
    J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk assessment model for the prognosis of osteosarcoma utilizing differentially expressed lncRNAs.
    Sun K; Zhao J
    Mol Med Rep; 2019 Feb; 19(2):1128-1138. PubMed ID: 30569146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma.
    Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S
    Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature.
    Guo JC; Li CQ; Wang QY; Zhao JM; Ding JY; Li EM; Xu LY
    Mol Biosyst; 2016 Oct; 12(11):3467-3477. PubMed ID: 27714034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients.
    Zhang GZ; Wu ZL; Li CY; Ren EH; Yuan WH; Deng YJ; Xie QQ
    Front Mol Biosci; 2021; 8():615084. PubMed ID: 34095215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.